A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis

NCT02473393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Bacterial Enteritis

Interventions

DRUG: OPS-2071 tablet

Sponsor

Otsuka Pharmaceutical Co., Ltd.